Interpace Biosciences Inc. (IDXG)

[Avoid]

shares outstanding are really around 5 million shares

David T. Veal, Morgan Stanley, Research Division - Research Analyst [21]

--------------------------------------------------------------------------------

My question is, what is the public float on the shares? And what kind of a -- the volume has been tremendous all year long, and what is your best guess on where the buying and selling is coming from?

--------------------------------------------------------------------------------

Jack E. Stover, Interpace Diagnostics Group, Inc. - CEO, President and Director [22]

--------------------------------------------------------------------------------

Yes, David. Thanks for joining us. Yes, as we take a look at the float, I'll give you a sense of where is -- or where it was on a presplit basis. Before our financings and the restructuring, we had a roughly 18 million shares outstanding. And our float at that time was basically about 11 million shares. Add to that some of the financings that have taken place and changes, et cetera, but the reverse stock split was effectively a 1-for-10 reverse stock split. So we're probably somewhere in that range. But in total, our shares outstanding are really around 5 million shares. And today, I believe we traded around 2 million shares. So there's a lot of interest in the stock. Quite frankly, while I'm very interested in it, and I spend a lot of time talking to prospective investors, we don't have a lot of time to really track down the investment process as to who's in and who's out and how that activity happens. But we're certainly thrilled to see the kind of volume we have and the kind of support we have in the marketplace.


http://finance.yahoo.com/news/edited-transcript-idxg-earnings-conference-030721618.html

$IDXG